Plain-English translation of NCT07805551 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called , given together with other standard colorectal cancer drugs, to see if it works better and is safe for people with advanced colorectal cancer. The study has two phases: first, doctors will find the right dose of the medication by testing it in small groups of patients; then, they'll test that dose in a larger group to see how well it actually works.
Advanced colorectal cancer is hard to treat, and current options don't work for everyone. This trial is exploring whether adding this medication to existing cancer treatments might help more patients live longer and with fewer side effects.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would receive the new medication combined with other standard colorectal cancer drugs, either through infusions or pills depending on which treatment group you're assigned to. You'll visit the clinic regularly for blood tests, scans, and doctor check-ups to monitor how well the treatment is working and watch for side effects. The study is divided into two phases, so you may be part of finding the right dose or testing it in a larger patient group.
AI-generated summary from trial data ยท Nov 17, 2026 ยท Not medical advice
China